Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol in Parkinson's Disease
NCT06612593Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilostazol in Parkinson's disease (PD), sponsored by Ain Shams University. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
cilostazol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06612593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06612593.